Effexor and Osteomyelitis acute - a phase IV clinical study of FDA data

Summary:

Osteomyelitis acute is reported as a side effect among people who take Effexor (venlafaxine hydrochloride), especially for people who are female, 50-59 old, also take Zometa, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Osteomyelitis acute when taking Effexor. It is created by eHealthMe based on reports of 92,291 people who have side effects when taking Effexor from the FDA, and is updated regularly.

What is Effexor?

Effexor has active ingredients of venlafaxine hydrochloride. It is often used in depression. eHealthMe is studying from 99,493 Effexor users. Check the latest studies of Effexor.

What is Osteomyelitis acute?

Osteomyelitis acute (rapid infection of bone) is found to be associated with 144 drugs and 160 conditions by eHealthMe. Check the latest studies of Osteomyelitis acute.

On Jul, 07, 2026

92,291 people reported to have side effects when taking Effexor.
Among them, 35 people (0.04%) have Osteomyelitis acute.

Could Effexor cause Osteomyelitis acute?

Among these 35 people:

What is the gender of people who have Osteomyelitis acute when taking Effexor? *

female: 100 %
male: 0.0 %

What is the age of people who have Osteomyelitis acute when taking Effexor? *

What are other drugs people take besides Effexor? *

Zometa: 29 people, 82.86%
Lortab: 23 people, 65.71%
Aranesp: 19 people, 54.29%
Keppra: 18 people, 51.43%
Revlimid: 18 people, 51.43%
Neurontin: 18 people, 51.43%
Oxycontin: 18 people, 51.43%
Percocet: 18 people, 51.43%
Flexeril: 18 people, 51.43%
Dexamethasone Sodium Phosphate: 18 people, 51.43%

What are other side effects people have besides Osteomyelitis acute? *

Osteonecrosis Of Jaw (death of bone of jaw): 32 people, 91.43%
Pain: 32 people, 91.43%
Osteolysis (dissolution of bone): 31 people, 88.57%
Infection: 26 people, 74.29%
Hypotension (abnormally low blood pressure): 26 people, 74.29%
Injury: 26 people, 74.29%
Plasmacytoma (neoplasm of plasma cells (usually in bone marrow)): 26 people, 74.29%
Anaemia (lack of blood): 26 people, 74.29%
Tooth Loss: 25 people, 71.43%
Oedema Peripheral (superficial swelling): 25 people, 71.43%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 20 people, 57.14%
Pain: 8 people, 22.86%
Bone Disorder: 6 people, 17.14%
Osteoporosis (bones weak and more likely to break): 2 people, 5.71%
Metastases To Bone (cancer spreads to bone): 1 person, 2.86%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 2.86%

* Approximation only. Some reports may have incomplete information.

Do you take Effexor and have Osteomyelitis acute?

- Check whether Osteomyelitis acute is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Effexor:

Effexor (99,493 reports)

Browse all side effects of Effexor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Osteomyelitis acute:

Osteomyelitis acute (144 drugs)

Browse all the conditions that are associated with Osteomyelitis acute:

Osteomyelitis acute (160 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on venlafaxine hydrochloride (the active ingredients of Effexor) and Effexor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.